Screener
Bio-Techne TECH Instruments — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Quarter Ended / March 31, 2026 | Quarter Ended / March 31, 2025 | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|---|---|
| Consumables | $257,338 | $257,785 | $724,382 | $719,345 |
| Instruments | 27,664 | 26,111 | 79,095 | 83,185 |
| Services | 21,446 | 27,246 | 71,244 | 81,953 |
| Total product and services revenue, net | $306,448 | $311,142 | $874,721 | $884,483 |
| Royalty revenues | 4,967 | 5,039 | 19,126 | 18,188 |
| Total revenues, net | $311,415 | $316,181 | $893,847 | $902,671 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's instruments — revenue?
- Bio-Techne (TECH) reported instruments — revenue of $27.66M in Q1 2026.
- How has Bio-Techne's instruments — revenue changed year-over-year?
- Bio-Techne's instruments — revenue increased by 5.9% year-over-year, from $26.11M to $27.66M.
- What is the long-term trend for Bio-Techne's instruments — revenue?
- Over 3 years (2022 to 2025), Bio-Techne's instruments — revenue has grown at a -2.5% compound annual growth rate (CAGR), from $120.76M to $112.09M.
- What does instruments — revenue mean?
- This metric represents the total net sales generated specifically from the sale of analytical instruments within the company's portfolio, excluding any applicable sales taxes. It serves as a key indicator of the demand for the company's hardware-based research and diagnostic solutions, reflecting the adoption rate of its capital equipment among life sciences and clinical customers. This revenue stream is distinct from consumable reagents and provides insight into the company's ability to capture market share in the laboratory instrumentation space.
Ask your AI about Bio-Techne's instruments — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude